Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT02272790 · COMPLETED

Trial details

NCT number: NCT02272790
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation

Start date: 2015-01-30
Primary completion: 2018-12-13
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.